SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →LABD
LABD, or Direxion Daily S&P Biotech Bear 3X Shares, is an exchange-traded fund (ETF) designed to provide three times the inverse of the daily performance of the S&P Biotechnology Select Industry Index. LABD seeks to deliver -3x the daily return of the underlying index.
- Open
- 8.58
- High
- 9.16
- Low
- 8.18
- Prev close
- 8.41
- Volume
- 19M
- Avg vol 10
- 25M
Today · Market closed · opens Mon 9:30 AM
LABD chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 9.00
Leaning buy. 7 of 18 signals point up against 4 down, carried by momentum and trend. Volatility leans sell. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in overbought territory. Trend strength is weak (ADX 15).
Trend
Momentum
Volatility
Volume
Strong buy. The close is above 19 of 24 averages and below 5. Short- and long-term averages agree: price is above both. SMA 50 is below SMA 200 (7.55 vs 11.45).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 8.39 | 8.38 | 8.53 | 8.04 |
| 10 | 7.67 | 7.98 | 8.08 | 7.73 |
| 20 | 7.42 | 7.71 | 7.65 | 7.61 |
| 50 | 7.55 | 7.65 | 7.60 | 8.46 |
| 100 | 7.53 | 8.46 | 7.47 | 10.56 |
| 200 | 11.45 | 10.61 | 9.10 | 13.11 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is R1 at 8.74. Nearest resistance is R2 at 9.08.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 9.98 | 9.08 | 8.66 | 9.64 | 10.03 | — |
| R2 | 9.08 | 8.73 | 8.57 | 9.08 | 9.27 | — |
| R1 | 8.74 | 8.52 | 8.49 | 8.74 | 9.13 | 8.91 |
| Pivot | 8.18 | 8.18 | 8.18 | 8.18 | 8.37 | 8.26 |
| S1 | 7.84 | 7.83 | 8.33 | 7.84 | 8.23 | 8.01 |
| S2 | 7.28 | 7.62 | 8.25 | 7.28 | 7.47 | — |
| S3 | 6.38 | 7.28 | 8.16 | 6.94 | 7.33 | — |
Patterns that formed on the last 5 bars, newest first.
An engulfing pattern (a candle swallowing the one before) followed by a third candle that closes further the same way.
A confirmed engulfing: a turn up from a decline.
A candle whose body completely covers the body of the one before it, in the opposite colour.
Buyers overwhelmed the previous session's selling; after a decline a turn up may follow.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A doji with long shadows both ways.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A long candle with no shadow at the close: it closed at its high (bullish) or its low (bearish).
Buyers held control into the close.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 8.68 | 9.16 | 8.18 | 9.00 | 19M | +0.32 |
| Nov 19, 2026 | 8.24 | 8.51 | 7.61 | 8.41 | 30M | +0.17 |
| Nov 18, 2026 | 8.28 | 8.36 | 7.82 | 8.25 | 26M | −0.03 |
| Nov 17, 2026 | 7.90 | 8.54 | 7.81 | 8.22 | 37M | +0.32 |
| Nov 16, 2026 | 7.51 | 8.16 | 7.28 | 8.09 | 24M | +0.58 |
| Nov 13, 2026 | 7.39 | 7.76 | 7.32 | 7.42 | 28M | +0.03 |
| Nov 12, 2026 | 6.94 | 7.39 | 6.90 | 7.30 | 35M | +0.36 |
| Nov 11, 2026 | 6.71 | 6.86 | 6.58 | 6.66 | 21M | −0.05 |
| Nov 10, 2026 | 6.80 | 7.05 | 6.47 | 6.82 | 12M | +0.02 |
| Nov 9, 2026 | 7.08 | 7.42 | 6.44 | 6.58 | 17M | −0.50 |
| Nov 6, 2026 | 7.76 | 8.00 | 7.13 | 7.24 | 27M | −0.52 |
| Nov 5, 2026 | 6.72 | 7.85 | 6.69 | 7.83 | 49M | +1.11 |
| Nov 4, 2026 | 6.70 | 7.41 | 6.51 | 6.51 | 42M | −0.19 |
| Nov 3, 2026 | 7.37 | 7.42 | 6.80 | 7.08 | 25M | −0.29 |
| Nov 2, 2026 | 6.92 | 7.55 | 6.83 | 7.51 | 21M | +0.59 |
| Oct 30, 2026 | 6.88 | 7.20 | 6.50 | 6.98 | 23M | +0.10 |
| Oct 29, 2026 | 6.77 | 6.92 | 6.43 | 6.75 | 23M | −0.02 |
| Oct 28, 2026 | 7.34 | 7.43 | 6.77 | 6.77 | 27M | −0.57 |
| Oct 27, 2026 | 7.86 | 8.01 | 7.13 | 7.14 | 19M | −0.72 |
| Oct 26, 2026 | 7.89 | 7.98 | 7.59 | 7.81 | 12M | −0.08 |
| Oct 23, 2026 | 7.83 | 8.25 | 7.79 | 7.96 | 17M | +0.13 |
| Oct 22, 2026 | 7.60 | 7.92 | 7.23 | 7.62 | 32M | +0.02 |
| Oct 21, 2026 | 7.36 | 7.48 | 7.04 | 7.46 | 16M | +0.10 |
| Oct 20, 2026 | 8.21 | 8.32 | 7.29 | 7.41 | 21M | −0.80 |
| Oct 19, 2026 | 8.67 | 8.79 | 8.17 | 8.29 | 22M | −0.38 |
| Oct 16, 2026 | 8.03 | 9.03 | 8.02 | 8.96 | 30M | +0.93 |
| Oct 15, 2026 | 8.43 | 8.56 | 7.89 | 8.05 | 21M | −0.38 |
| Oct 14, 2026 | 8.73 | 8.88 | 8.24 | 8.64 | 22M | −0.09 |
| Oct 13, 2026 | 8.02 | 8.60 | 7.95 | 8.59 | 24M | +0.57 |
| Oct 12, 2026 | 7.52 | 7.91 | 7.46 | 7.86 | 15M | +0.34 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
19.55%
Change in value over the past month.
3 month return
40.59%
Change in value over the last three months.
Max drawdown
73.22%
Largest fall from a peak to the low that followed.
Standard deviation
93.09%
How far daily returns stray from their average, annualised.
Sharpe ratio
-0.56
Return above the risk-free rate per unit of volatility.
Calmar ratio
-0.71
Annualised return against the maximum drawdown.
LABD summary
Loading summary…
LABD, answered
What is the expense ratio of LABD?
LABD has an expense ratio of approximately 1.07%. This fee covers the costs of managing the fund, including administrative and operational expenses, expressed as a percentage of the fund’s average net assets.
Can LABD be used in a retirement account?
Yes, LABD can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it is essential to consider how it fits within your overall investment strategy and risk tolerance.
What are the risks associated with investing in LABD?
Risks include high volatility and potential for significant losses due to LABD’s leveraged inverse exposure. The ETF's performance is highly sensitive to daily movements in the biotech sector, and leverage can amplify both gains and losses.
How is LABD managed?
LABD is managed by Direxion Funds and employs leverage through financial instruments such as futures contracts, options, and swap agreements. The fund aims to maintain its -3x leverage ratio through daily rebalancing.
How does LABD’s use of leverage impact its performance?
LABD uses leverage to amplify its inverse exposure to the biotech sector, targeting -3x the daily performance of the S&P Biotechnology Select Industry Index. Leverage can lead to significant performance fluctuations, particularly over periods longer than one day due to compounding effects.
What are the key performance metrics for LABD?
Key performance metrics for LABD include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABD targets -3x the daily performance of the S&P Biotechnology Select Industry Index.
How can I invest in LABD?
Investors can buy shares of LABD through a brokerage account. The ETF is traded on major stock exchanges under the ticker symbol "LABD" and can be bought and sold like other stocks and ETFs.
What factors can affect the performance of LABD?
Factors influencing LABD’s performance include movements in the biotech sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. LABD’s daily rebalancing and compounding effects also impact performance.
How does LABD’s performance compare to the S&P Biotechnology Select Industry Index?
LABD aims to deliver three times the inverse (-3x) of the daily performance of the S&P Biotechnology Select Industry Index. Over time, due to the effects of compounding and daily rebalancing, its performance may differ significantly from the index.
What are some similar ETFs to LABD?
Similar ETFs to LABD include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide 3x the daily performance of the S&P Biotechnology Select Industry Index, the opposite of LABD’s objective; XBI (SPDR S&P Biotech ETF), which provides exposure to the biotechnology sector without leverage; and BIB (Direxion Daily S&P Biotech Bull 2X Shares), which provides 2x the daily performance of the S&P Biotechnology Select Industry Index, less leveraged compared to LABD.
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Unleash Your LABD Trading Now
Experience the future of trading with OHLCX Markets. Our advanced system delivers in-depth analysis and insights for LABD, utilizing state-of-the-art technical tools and strategies. Transform your trading strategy now and see how we can elevate your trading results!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.